BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-216

  1. 2,054 Posts.
    lightbulb Created with Sketch. 1466
    "...there is a premium already priced into this stock..."

    Agreed - it is entirely possible professional investment firms such as Euroz Hartley and E&P are way off on their predicted prices (shared in May '24), perhaps even missing their grip on reality like the average punter, and expecting the market to be forward looking which of course it isn't:

    E&P:
    https://hotcopper.com.au/data/attachments/6253/6253599-47c81544fb4adc195b3e6ac15e98d3db.jpg

    Hartleys:
    https://hotcopper.com.au/data/attachments/6253/6253592-6027b6c4a6783acf65dc7cb8222b20a5.jpg

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.